Skip to main content
. 2007 Dec 28;190(5):1595–1604. doi: 10.1128/JB.01718-07

TABLE 3.

Oligonucleotides used in this study

Application Name Sequence and restriction sitea
Construction of pT7-7 StrepIIVirB5 VirB5-5′ 5′-CAGGGTACCCAGTTCGTTGTCAGCGATCCGGCG-3′
    and pT7-7H6TrxA-VirB5 VirB5-3′ 5′-GAGCTGCAGTCAGGGGACGGCCCCAAAGATG-3′
Construction of pAS2-Tzs and AS2-Tzs-5′ 5′-GGAGGCTCATGATACTCCATCTCATCTACGGACC-3′
    pACTII-Tzs AS2-Tzs-3′ 5′-GACGGGGATCCTCACCGAATTCGCGTCAGCGTG-3′
Cloning of virB2 B2-5 5′-CCACACGAATTCCAAGTCGTGATGGACCGTCTCGA-3′
B2-3 5′-CCACACGAATTCGACGGCAACGTGCATTGCGCATTT-3′
Deletion of virB2 ΔB2-5 5′-AGGAGGTCCGCAATAATGAATGATCGTCTGGAAGCAACCCTT-3′
ΔB2-3 5′-TTATTGCGGACCTCCTTGATTTAAGTCGAACAAGAGTTGATCGTC-3′
Cloning of virB8 B8-5 5′-CGCAGTCTAGAGCAAAGTGGATCGGGCAACTTAT-3′
B8-3 5′-CGCAGTCTAGACCTCTGCTCTCTGTTGATATTGCGCTT-3′
Deletion of virB8 ΔB8-5 5′-CCGTGCTCGAGTTATTCAGACCCCTTCATGGCGACCACCT-3′
ΔB8-3 5′-CCGTGCTCGAGATGACGAAAAAAGCATTTCTCA-3′
a

Restriction enzyme cleavage sites are underlined.